RecruitingPhase 2NCT07527650
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
Sponsor: Hanmi Pharmaceutical Company Limited
Jefferson City, MO · Kansas City, MO · +18 more sites
Type 2 Diabetes clinical trials in Kansas City, MO
11 recruiting type 2 diabetes studies with a site in Kansas City, MO.
RecruitingPhase 3NCT07064473
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Sponsor: Boehringer Ingelheim
Jefferson City, MO · Kansas City, MO · St Louis, MO · +205 more sites
RecruitingPhase 3NCT07667803
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Sponsor: AstraZeneca
Kansas City, MO · St Louis, MO · +54 more sites
RecruitingPhase 3NCT07776509
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Kansas City, MO · +22 more sites
RecruitingPhase 3NCT07784270
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Sponsor: AstraZeneca
Kansas City, MO · St Louis, MO · +51 more sites
RecruitingPhase 3NCT07662213
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Jefferson City, MO · Kansas City, MO · +62 more sites
RecruitingPhase 3NCT07662135
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Sponsor: AstraZeneca
Kansas City, MO · +32 more sites
RecruitingPhase 3NCT07662044
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Kansas City, MO · St Louis, MO · +25 more sites
RecruitingPhase 3NCT07784725
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Jefferson City, MO · Kansas City, MO · +31 more sites
RecruitingPhase not listedNCT06481904
Registry for Stage 2 Type 1 Diabetes
Sponsor: Sanofi
Kansas City, MO · +36 more sites
RecruitingPhase 2NCT06717698
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Sponsor: Novo Nordisk A/S
Kansas City, MO · +17 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.